(Q27025926)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859951%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

title

Viral hepatitis C gets personal--the value of human genomics to public health (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859951%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

0 references

0 references

1 reference

L Zhang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859951%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

M Gwinn

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859951%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

D J Hu

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859951%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

language of work or name

1 reference

11 July 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859951%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

published in

Public Health Genomics

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859951%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

volume

16

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859951%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

issue

4

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859951%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

192-197

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859951%20AND%20SRC:MED&resulttype=core&format=json

Estimating future hepatitis C morbidity, mortality, and costs in the United States

5 March 2020

cites work

1 reference

12 December 2020

Genome of human hepatitis C virus (HCV): gene organization, sequence diversity, and variation

1 reference

12 December 2020

Natural history of chronic hepatitis C

1 reference

12 December 2020

Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS.

1 reference

12 December 2020

Evasion of intracellular host defence by hepatitis C virus

1 reference

12 December 2020

Mechanism of action of interferon and ribavirin in treatment of hepatitis C

1 reference

12 December 2020

Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

1 reference

12 December 2020

Changing trends in hepatitis C-related mortality in the United States, 1995-2004.

1 reference

12 December 2020

Peginterferon Pharmacokinetics in African American and Caucasian American Patients With Hepatitis C Virus Genotype 1 Infection

1 reference

12 December 2020

Treatment predictors of a sustained virologic response in hepatitis B and C.

1 reference

12 December 2020

Critical role for constitutive type I interferon signaling in the prevention of cellular transformation.

1 reference

12 December 2020

The global burden of hepatitis C

1 reference

12 December 2020

Telaprevir and peginterferon with or without ribavirin for chronic HCV infection

1 reference

12 December 2020

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection

1 reference

12 December 2020

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

12 December 2020

Trends in hepatitis C virus infection among patients in the HIV Outpatient Study, 1996-2007.

1 reference

12 December 2020

Interferon-alfa, interferon-lambda and hepatitis C.

1 reference

12 December 2020

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

1 reference

12 December 2020

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

1 reference

12 December 2020

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

1 reference

12 December 2020

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

1 reference

12 December 2020

Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus

1 reference

12 December 2020

Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection

1 reference

12 December 2020

Direct economic burden of chronic hepatitis C virus in a United States managed care population

1 reference

12 December 2020

A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice

1 reference

12 December 2020

IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection

1 reference

12 December 2020

Protective interleukin-28B genotype affects hepatitis C virus clearance, but does not contribute to HIV-1 control in a cohort of African-American elite controllers/suppressors

1 reference

12 December 2020

Hepatitis C virus: How genetic variability affects pathobiology of disease

1 reference

12 December 2020

Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy

1 reference

12 December 2020

Boceprevir for untreated chronic HCV genotype 1 infection

1 reference

12 December 2020

IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin

1 reference

12 December 2020

IL28B but not ITPA polymorphism is predictive of response to pegylated interferon, ribavirin, and telaprevir triple therapy in patients with genotype 1 hepatitis C

1 reference

12 December 2020

Telaprevir for previously untreated chronic hepatitis C virus infection

1 reference

12 December 2020

IL28B genotype does not correlate with HIV control in African Americans

1 reference

12 December 2020

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

1 reference

12 December 2020

Host genomics and HCV treatment response.

1 reference

12 December 2020

Single nucleotide polymorphisms of the IL28B and sustained virologic response of patients with chronic hepatitis C to PEG-interferon/ribavirin therapy: A meta-analysis: Meta-analysis of IL28B.

1 reference

12 December 2020

The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007.

1 reference

12 December 2020

New protease inhibitors for the treatment of chronic hepatitis C: a cost-effectiveness analysis

1 reference

12 December 2020

Will IL28B polymorphism remain relevant in the era of direct-acting antiviral agents for hepatitis C virus?

1 reference

12 December 2020

Clinical utility of interleukin-28B testing in patients with genotype 1.

1 reference

12 December 2020

Genetic factors and hepatitis C virus infection

1 reference

12 December 2020

Meta-analysis: IL28B polymorphisms predict sustained viral response in HCV patients treated with pegylated interferon-α and ribavirin

1 reference

12 December 2020

Meta-analysis: IL-28B genotype and sustained viral clearance in HCV genotype 1 patients

1 reference

12 December 2020

Evolving epidemiology of hepatitis C virus in the United States

1 reference

12 December 2020

Impact of adverse events on costs and quality of life in protease inhibitor-based combination therapy for hepatitis C.

1 reference

12 December 2020

Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.

1 reference

12 December 2020

Hepatitis C virus testing of persons born during 1945-1965: recommendations from the Centers for Disease Control and Prevention

1 reference

12 December 2020

Interleukin-28B rs12979860C/T and rs8099917T/G contribute to spontaneous clearance of hepatitis C virus in Caucasians.

1 reference

12 December 2020

Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C.

1 reference

12 December 2020

Identifiers

DOI

10.1159/000352014

2 references

Consolidated OpenCitations Corpus – April 2017

2706030

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859951%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

2706030

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859951%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

PubMed publication ID

23859951

2 references

Consolidated OpenCitations Corpus – April 2017

2706030